STRATEC Biomedical's market cap is currently ―. The company's EPS TTM is €1.075; its P/E ratio is 36.37; and it has a dividend yield of 2.49%. STRATEC Biomedical is scheduled to report earnings on April 26, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	€ 66.97M	€ 70.46M	€ 61.81M	€ 75.39M	€ 61.91M
Gross Profit	€ 16.13M	€ 25.53M	€ 15.22M	€ 22.62M	€ 16.71M
EBIT	€ 5.55M	€ 16.11M	€ 5.23M	€ 14.10M	€ 4.53M
EBITDA	€ 9.82M	€ 20.25M	€ 9.38M	€ 18.46M	€ 8.85M
Net Income Common Stockholders	€ 4.50M	€ 12.12M	€ 1.43M	€ 11.17M	€ 3.61M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	€ 24.07M	€ 41.10M	€ 50.28M	€ 50.95M	€ 48.72M
Total Assets	€ 397.50M	€ 398.54M	€ 385.44M	€ 386.91M	€ 368.52M
Total Debt	€ 87.15M	€ 0.00	€ 0.00	€ 0.00	€ 85.30M
Net Debt	€ 63.08M	€ -41.10M	€ -50.28M	€ -50.95M	€ 36.57M
Total Liabilities	-	€ 183.97M	€ 181.03M	€ 169.37M	€ 162.77M
Stockholders Equity	€ 225.18M	€ 214.57M	€ 204.41M	€ 217.54M	€ 205.76M
Cash Flow	-
Free Cash Flow	€ -18.88M	€ -6.65M	€ 19.95M	€ -3.16M	€ 8.12M
Operating Cash Flow	€ -12.01M	€ -2.47M	€ 23.98M	€ 773.00K	€ 12.95M
Investing Cash Flow	€ -2.08M	€ -9.00M	€ -4.01M	€ -3.91M	€ -4.78M
Financing Cash Flow	€ 2.83M	€ -1.99M	€ -20.03M	€ 5.09M	€ -7.38M

Currency in EUR

STRATEC Biomedical Earnings and Revenue History

Income Statement >

STRATEC Biomedical Debt to Assets

Balance Sheet >

STRATEC Biomedical Cash Flow

Cash Flow >

STRATEC Biomedical Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing